Related Experiment Video
Updated: Jul 4, 2026

Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
Published on: September 25, 2019
Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator
Background And Purpose:
MRI is useful for detecting early ischemic lesions before administration of tissue plasminogen activator in patients with hyperacute ischemic stroke. However, it is unclear whether early ischemic change seen on diffusion-weighted imaging (DWI) can be used to predict patient outcomes.
Methods:
Consecutive patients with anterior circulation ischemic stroke treated with tissue plasminogen activator within 3 hours of stroke onset were prospectively studied. The National Institutes of Health Stroke Scale score was obtained before and 7 days after tissue plasminogen activator administration. MRI, including DWI, was done before tissue plasminogen activator thrombolysis. The relationship between the DWI Alberta Stroke Programme Early CT Score (ASPECTS) and patients' outcomes was assessed.
Results:
The subjects consisted of 49 consecutive patients with stroke (27 males; mean age, 72.9+/-10.3 years). The median (range) of the baseline DWI ASPECTS value was 9 (3-10). Dramatic improvement was seen in one of 8 patients with an ASPECTS < or = 5 compared with 21 of 41 patients with a DWI ASPECTS > 5 (P=0.0592). On the other hand, worsening was noted more frequently in patients with a DWI ASPECTS < or = 5 (3 of 8 patients) than in patients with an ASPECTS > 5 (4 of 41 patients; P=0.0753). Bad outcome was seen more frequently in patients with a DWI ASPECTS < or = 5 (6 of 8 patients) than in patients with a DWI ASPECTS > 5 (2 of 41 patients; P<0.0001). Multivariate logistic regression analysis demonstrated that a DWI ASPECTS < or = 5 was the only independent predictor of a bad outcome (OR, 33.4; 95% CI, 2.7 to 410.8; P=0.0062).
Conclusions:
DWI ASPECTS appears to be a reliable tool for predicting bad outcome. Patients with a DWI ASPECTS > 5 should be considered eligible for tissue plasminogen activator therapy.
Insights
Diffusion-weighted imaging Alberta Stroke Programme Early CT Score (DWI ASPECTS) predicts outcomes in acute ischemic stroke patients treated with tissue plasminogen activator. A low DWI ASPECTS score indicates a higher risk of poor outcomes.
Area of Science:
- Neurology
- Radiology
- Emergency Medicine
Background:
- Magnetic Resonance Imaging (MRI) detects early ischemic lesions in hyperacute stroke.
- Predictive value of early ischemic changes on diffusion-weighted imaging (DWI) for patient outcomes remains unclear.
Purpose of the Study:
- To assess the relationship between DWI Alberta Stroke Programme Early CT Score (ASPECTS) and patient outcomes.
- To determine if DWI ASPECTS can predict outcomes in patients receiving tissue plasminogen activator (tPA).
Main Methods:
- Prospective study of anterior circulation ischemic stroke patients treated with tPA within 3 hours.
- MRI including DWI performed before tPA administration.
- National Institutes of Health Stroke Scale (NIHSS) scores recorded pre- and post-tPA.
Main Results:
- 49 patients studied; median baseline DWI ASPECTS was 9.
- Patients with DWI ASPECTS ≤ 5 showed trends toward less dramatic improvement and more frequent worsening.
- A DWI ASPECTS ≤ 5 was the sole independent predictor of a bad outcome (OR, 33.4; P=0.0062).
Conclusions:
- DWI ASPECTS is a reliable predictor of poor outcomes in acute ischemic stroke.
- Patients with DWI ASPECTS > 5 are likely eligible for tPA therapy.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
